Physician profile
John Q Dickey
NPI 1588657076
$6,574.70
in general payments reported to CMS, 2019-2025
31 companies · $1,006 in 2025
The $1,006 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,007 · 2020: $542 · 2021: $762 · 2022: $637 · 2023: $1,496 · 2024: $1,125 · 2025: $1,006.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,626.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,626.30 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $1,593.45 | 2019-2025 | Aveir, Xience Skypoint, Jot Dx |
| Kestra Medical Technology Services, INC. | $637.81 | 2023-2025 | Assure Wcd |
| Inari Medical, INC. | $630.88 | 2020-2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $491.93 | 2022-2024 | Lifevest |
| Boston Scientific Corporation | $427.15 | 2021-2025 | Eluvia, Ranger |
| Philips North America LLC | $350.66 | 2024-2025 | Eagle Eye, Encore, (5044) Mcot |
| Penumbra, INC. | $283.63 | 2024-2025 | Indigo System |
| Abiomed | $263.77 | 2021-2022 | |
| Edwards Lifesciences Corporation | $155.24 | 2023 | Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Angiodynamics, INC. | $141.24 | 2023 | Alphavac |
| Cardiovascular Systems INC. | $131.76 | 2020 | |
| Ekos Corporation | $129.81 | 2019 | |
| Bracco Diagnostics INC. | $121.59 | 2019 | |
| Kiniksa Pharmaceuticals, LTD. | $118.03 | 2021-2023 | Arcalyst |
| Cardiva Medical, INC. | $117.88 | 2023 | Cardiva Vascade 6/7f Vcs |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $116.83 | 2019 | |
| Zoll Circulation INC | $100.00 | 2022 | |
| Medtronic Vascular, INC. | $94.94 | 2019 | |
| Medtronic, INC. | $86.42 | 2022-2025 | Venaseal |
| Pfizer INC. | $83.70 | 2021-2023 | |
| Shockwave Medical, INC | $82.50 | 2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Novartis Pharmaceuticals Corporation | $80.11 | 2019 | |
| Janssen Pharmaceuticals, INC | $67.73 | 2019-2021 | |
| E.R. Squibb & Sons, L.L.C. | $66.13 | 2019-2024 | Eliquis |
| Astellas Pharma US INC | $62.48 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $35.76 | 2020-2023 | Farxiga |
| Bayer Healthcare Pharmaceuticals INC. | $30.35 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $26.91 | 2024 | Jardiance |
| Merck Sharp & Dohme LLC | $18.05 | 2024 | Verquvo |
| Actelion Pharmaceuticals US, INC. | $16.86 | 2019 | |
| Preventice Services, LLC | $11.10 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Dickey listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.